The DOI matches its Crossref record; 275 of the 275 references it cites were found in a registry or an index.
Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies, and is also the fourth most common cancer worldwide with around 700,000 new cases each year. Currently, first line chemotherapeutic drugs used for HCC include fluorouracil, cisplatin, doxorubicin, paclitaxel and mitomycin, but most of these are non-selective cytotoxic molecules with significant side effects. Sorafenib is the only approved targeted therapy by the U.S. Food and Drug Administration for HCC treatment, but patients suffer from various kinds of adverse effects, including hypertension. The signal-transducer-and-activator-of-transcription 3 (STAT3) protein, one of the members of STATs transcription factor family, has been implicated in signal transduction by different cytokines, growth factors and oncogenes. In normal cells, STAT3 activation is tightly controlled to prevent dysregulated gene transcription, whereas constitutively activated STAT3 plays an important role in tumorigenesis through the upregulation of genes involved in anti-apoptosis, proliferation and angiogenesis. Thus, pharmacologically safe and effective agents that can block STAT3 activation have the potential both for the prevention and treatment of HCC. In the present review, we discuss the possible role of STAT3 signaling cascade and its interacting partners in the initiation of HCC and also analyze the role of various STAT3 regulated genes in HCC progression, inflammation, survival, invasion and angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–275 of 275
Rajendran, P., Li, F., Manu, K. A., Shanmugam, M. K., Loo, S. Y., Kumar, A. P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01187.x · Cited by 132
Self-citationPoon, R. T., Ng, I. O., Lau, C. P.-Y., et al. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(01)00708-5 · Cited by 131
Gauzzi, M. C., Barbieri, G., Richter, M. F., Uzé, G., Ling, L. E., Fellous, M., & Pellegrini, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11839 · Cited by 130
Interaction of hepatitis C virus proteins with host cell membranes and lipids
Dubuisson, J., Pénin, F., & Moradpour, D. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02383-8 · Cited by 130
STAT5 Interaction with the T Cell Receptor Complex and Stimulation of T Cell Proliferation
Welte, T., Leitenberg, D., Dittel, B. N., al-Ramadi, B. K., Xie, B., Chin, Y. E., Janeway, C. A., Bothwell, A. L. M., Bottomly, K., & Fu, X.-Y. (1999) · Science · doi:10.1126/science.283.5399.222 · Cited by 130
Murphy, S. M., Bergman, M., & Morgan, D. O. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5290 · Cited by 127
Novak, U., Harpur, A. G., Paradiso, L., Kanagasundaram, V., Jaworowski, A., Wilks, A. F., & Hamilton, J. (1995) · Blood · doi:10.1182/blood.v86.8.2948.2948 · Cited by 125
Etiology, pathology, and treatment of hepatocellular carcinoma in North America
Tabor, E., DIBISCEGLIE, A., & Purcell, R. H. (1991) · Medical Entomology and Zoology · Cited by 124
Ma, J., & Cao, X. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.016 · Cited by 122
Tai, W., Cheng, A., Shiau, C., Liu, C., Ko, C.-H., Lin, M.-W., Chen, P., & Chen, K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0412 · Cited by 122
Oates, A. C., Patrik, W., Pratt, S. J. P., Paw, B. H., Johnson, S. L., Ho, R. K., Postlethwait, J. H., Zon, L. I., & Wilks, A. F. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199908)215:4<352::aid-aja7>3.0.co;2-j · Cited by 119
A Stat3-interacting protein (StIP1) regulates cytokine signal transduction
Collum, R. G., Brutsaert, S., Lee, G., & Schindler, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170192197 · Cited by 114
Wang, Y.-Z., Wharton, W., Garcia, R., Kraker, A. J., Jove, R., & Pledger, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203548 · Cited by 114
Fletcher, S., Turkson, J., & Gunning, P. T. (2008) · ChemMedChem · doi:10.1002/cmdc.200800123 · Cited by 105
Chaturvedi, P., Sharma, S., & Reddy, E. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3295 · Cited by 104
Yeoh, G. C., Ernst, M., Rose‐John, S., Akhurst, B., Payne, C. J., Long, S., Alexander, W. S., Croker, B. A., Grail, D., & Matthews, V. B. (2007) · Hepatology · doi:10.1002/hep.21535 · Cited by 103
Signal transducer and activator of transcription 3 inhibitors: a patent review
Page, B. D. G., Ball, D. P., & Gunning, P. T. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.539205 · Cited by 102
Sasaki, A. T., Inagaki‐Ohara, K., Yoshida, T., Yamanaka, A., Sasaki, M., Yasukawa, H., Koromilas, A. E., & Yoshimura, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200608200 · Cited by 102
The role of STATs in proliferation, differentiation, and apoptosis
Mui, A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050394 · Cited by 101
Richter, M. F., Duménil, G., Uzé, G., Fellous, M., & Pellegrini, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24723 · Cited by 96
Wang, Y., Ma, X., Yan, S., Shen, S., Zhu, H., Gu, Y. J., Wang, H., Qin, G., & Yu, Q. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0462 · Cited by 96
Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues
Emilsson, V., Arch, J. R. S., de Groot, R. P., Lister, C. A., & Cawthorne, M. A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00874-1 · Cited by 95
Nucleocytoplasmic shuttling of persistently activated STAT3
Herrmann, A., Vogt, M., Mönnigmann, M., Clahsen, T., Sommer, U., Haan, S., Poli, V., Heinrich, P. C., & Müller-Newen, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03482 · Cited by 94
Carlisi, D., D’Anneo, A., Angileri, L., Lauricella, M., Emanuele, S., Santulli, A., Vento, R., & Tesoriere, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22494 · Cited by 93
4-Aminobiphenyl DNA Damage in Liver Tissue of Hepatocellular Carcinoma Patients and Controls
Wang, L., Chen, C., Zhang, Y.-J., Tsai, W. Y., Lee, P., Feitelson, M. A., Lee, C.-S., & Santella, R. M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009452 · Cited by 93
Feng, D. Y. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i1.33 · Cited by 91
Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3
Gu, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3922 · Cited by 91
Choudhari, S. R., Khan, M. A., Harris, G., Picker, D., Jacob, G. S., Block, T., & Shailubhai, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0561 · Cited by 90 · cited 9×
“activation of upstream kinases c-Src, JAK1 and JAK2 HUH-7 and HepG2 [281]”
BackgroundInfluentialThe STAT family of proteins in cytokine signaling
Shuai, K. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00051-0 · Cited by 89
SHP‐1 suppresses cancer cell growth by promoting degradation of JAK kinases
Wu, C., Guan, Q., Wang, Y., Zhao, Z. J., & Zhou, G. W. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10727 · Cited by 83
(1998) · Springer eBooks · doi:10.1007/978-94-011-4932-7 · Cited by 81
Okada, M., Howell, B. W., Broome, M. A., & Cooper, J. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46812-8 · Cited by 81
Fuke, H., Shiraki, K., Sugimoto, K., Tanaka, J., Beppu, T., Yoneda, K., Yamamoto, N., Ito, K., Masuya, M., & Takei, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.049 · Cited by 79
Yang, S., Wang, S., Wu, C., Yeh, Y., Chai, C., Chunag, S.-C., Sheen, M., & Lee, K.-T. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.036970 · Cited by 78
Qiu, Z., Huang, C., Sun, J., Qiu, W., Zhang, J., Li, H., Jiang, T., Huang, K., & Cao, J. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00485.x · Cited by 77
Briggs, S. D., Bryant, S. S., Jove, R., Sanderson, S. D., & Smithgall, T. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14718 · Cited by 76
Liu, Y., Fuchs, J. R., Li, C., & Lin, J. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12946 · Cited by 72
Haan, C., Heinrich, P. C., & Behrmann, I. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3610105 · Cited by 71
Mechanisms of Viral Hepatitis Induced Liver Injury
Nakamoto, Y., & Kaneko, S. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479591 · Cited by 71
Ueno, H., Sasaki, K., Miyagawa, K., Honda, H., Mitani, K., Yazaki, Y., & Hirai, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8739 · Cited by 71
The JAK-STAT pathway in Drosophila
Hou, X. S., & Perrimon, N. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01006-8 · Cited by 71
Moser, C., Lang, S. A., Mori, A., Hellerbrand, C., Schlitt, H. J., Geissler, E. K., Fogler, W. E., & Stoeltzing, O. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-206 · Cited by 69
STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Lavecchia, A., Giovanni, C. D., & Novellino, E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843218 · Cited by 68
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
Duan, Z., Bradner, J. E., Greenberg, E. F., Levine, R. L., Foster, R., Mahoney, J., & Seiden, M. V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1330 · Cited by 67
Sachsenmaier, C., Sadowski, H. B., & Cooper, J. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202694 · Cited by 67
Inactivation of Stat3 in tumor cells
Gamero, A. M., Young, H. A., & Wiltrout, R. H. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00028-5 · Cited by 65
Liu, Y., Liu, A., Li, H., Li, C., & Lin, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0317 · Cited by 65
Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma
Shiraki, K., Sugimoto, K., Yamanaka, Y., Yamaguchi, Y., Saitou, Y., Ito, K., Yamamoto, N., Yamanaka, T., Fujikawa, K., Murata, K., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.5.705 · Cited by 63
Kusaba, M., Nakao, K., Goto, T., Nishimura, D., Kawashimo, H., Shibata, H., Motoyoshi, Y., Taura, N., Ichikawa, T., Hamasaki, K., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.017 · Cited by 63
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma
Lau, C. K., Yang, Z. F., Lam, S. P., Lam, C. T., Ngai, P., Tam, K. H., Poon, R. T. P., & Fan, S.-T. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.4970 · Cited by 62
Wilson, J. F. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00024 · Cited by 61
Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways
Yuan, F.-J., Zhou, W., Zou, C., Zhang, Z., Hu, H., Dai, Z., & Zhang, Y. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0509-3 · Cited by 58
Hilkens, C. M. U., Is’harc, H., Lillemeier, B. F., Strobl, B., Bates, P. A., Behrmann, I., & Kerr, I. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02783-1 · Cited by 58
Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center.
Wahab, M. A., el-Ghawalby, N., Mostafa, M., Sultan, A., Elsadany, M., Fathy, O. M., Salah, T., & EZZAT, F. A. (2007) · PubMed · Cited by 57
Torisu, T., Nakaya, M., Watanabe, S., Hashimoto, M., Yoshida, H., Chinen, T., Yoshida, R., Okamoto, F., Hanada, T., Torisu, K., et al. (2008) · Hepatology · doi:10.1002/hep.22214 · Cited by 56
Hepatitis viruses: live and let die
Herzer, K., Sprinzl, M. F., & Galle, P. R. (2007) · Liver International · doi:10.1111/j.1478-3231.2006.01422.x · Cited by 56
Obesity, Inflammatory Signaling, and Hepatocellular Carcinoma—An Enlarging Link
Toffanin, S., Friedman, S. L., & Llovet, J. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.018 · Cited by 53
Matsuda, Y., Ichida, T., Genda, T., Yamagiwa, S., Aoyagi, Y., & Asakura, H. (2003) · PubMed · Cited by 50
Chen, K., Su, J.-C., Liu, C., Huang, J., Chen, K.-C., Chen, W.-L., Tai, W., & Shiau, C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.023 · Cited by 50
Computational and Functional Analysis of the Putative SH2 Domain in Janus Kinases
Kampa, D., & Burnside, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3757 · Cited by 49
Dien, J., Amin, H. M., Chiu, N., Wong, W., Frantz, C., Chiu, B., Mackey, J. R., & Lai, R. L. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051109 · Cited by 48
STAT3 activation accompanies keratinocyte differentiation.
Hauser, P. J., Agrawal, D., Hackney, J. A., & Pledger, W. J. (1998) · PubMed · Cited by 48
Signal transducers and activators of transcription (STATs) : activation and biology
Sehgal, P. B., Levy, D. E., & Hirano, T. (2003) · Kluwer Academic Publishers eBooks · Cited by 43
p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis
Matsuda, Y., & Ichida, T. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0339-2 · Cited by 41
Osada, S., Saji, S., & Kuno, T. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.20006 · Cited by 39
Bagnyukova, T., Tryndyak, V., Muskhelishvili, L., Ross, S. A., Beland, F. A., & Pogribny, I. P. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6816 · Cited by 39
Won, C., Lee, C. S., Lee, J., Kim, T., Lee, K., Yang, Y. M., Kim, Y.-N., Ye, S., & Chung, M. (2010) · PubMed · Cited by 37
The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src
Summy, J. M., Qian, Y. R., Jiang, B., Guappone, A. C., Gatesman, A., Shi, X., & Flynn, D. C. (2003) · Journal of Cell Science · doi:10.1242/jcs.00466 · Cited by 37
STAT-3 activity in chemically-induced hepatocellular carcinoma
Sánchez, A., Nagy, P., & Thorgeirsson, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00393-9 · Cited by 34
XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells
Liu, Y., Liu, A., Xu, Z., Yu, W., Wang, H., Li, C., & Lin, J. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0578-0 · Cited by 33
Zhang, T., Seow, K. T., Ong, C. T., & Cao, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105525200 · Cited by 29
Nuclear retention of STAT3 through the coiled-coil domain regulates its activity
Sato, N., Tsuruma, R., Imoto, S., Sekine, Y., Muromoto, R., Sugiyama, K., & Matsuda, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.145 · Cited by 28
Mark, A. F. (2005) · Frontiers in bioscience · doi:10.2741/1640 · Cited by 27
Meng (2010) · Oncology Reports · doi:10.3892/or_00000960 · Cited by 27
Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP
Metz, S., Wiesinger, M., Vogt, M., Lauks, H., Schmalzing, G., Heinrich, P. C., & Müller‐Newen, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606885200 · Cited by 24
Cited by
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationNon-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 354
Loh, C.-Y., Arya, A., Naema, A. F., Wong, W. F., Sethi, G., & Looi, C. Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00048 · Cited by 348
Self-citationRole of nonresolving inflammation in hepatocellular carcinoma development and progression
Yu, L.-X., Ling, Y., & Wang, H.-Y. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 301
Metadata
- Authors
- Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., Hui, K. M., & Sethi, G.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 1835
- Issue
- 1
- Pages
- 46-60
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2018659577
- Cited by
- 278
- References
- 275
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.